Engeletin suppresses cervical carcinogenesis in vitro and in vivo by reducing NF-κB-dependent signaling
Authors:
- 30 March 2020
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 526 (2) , 497-504
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Protective and Therapeutic Effects of Engeletin on LPS-Induced Acute Lung InjuryInflammation, 2018
- Human papillomavirus E6 protein enriches the CD55(+) population in cervical cancer cells, promoting radioresistance and cancer aggressivenessThe Journal of Pathology, 2017
- MiR-211 inhibits invasion and epithelial-to-mesenchymal transition (EMT) of cervical cancer cells via targeting MUC4Biochemical and Biophysical Research Communications, 2017
- Integrated genomic and molecular characterization of cervical cancerNature, 2017
- Epigenetic regulation of epithelial–mesenchymal transitionCellular and Molecular Life Sciences, 2016
- TIMP-1 Overexpression in Lung Carcinoma Enhances Tumor Kinetics and Angiogenesis in Brain MetastasisJournal of Neuropathology & Experimental Neurology, 2015
- IL‐4 induces proliferation in prostate cancer PC3 cells under nutrient‐depletion stress through the activation of the JNK‐pathway and survivin up‐regulationJournal of Cellular Biochemistry, 2011
- TGF‐β1‐induced EMT of non‐transformed prostate hyperplasia cells is characterized by early induction of SNAI2/SlugThe Prostate, 2011
- The inflammatory chemokines CCL2 and CCL5 in breast cancerCancer Letters, 2008
- The absence of CCL2 expression in cervical carcinoma is associated with increased survival and loss of heterozygosity at 17q11.2The Journal of Pathology, 2006